We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Lung and Tracheal Tissue Expected to Aid Respiratory Disease Research

By Gerald M. Slutzky, PhD
Posted on 25 Nov 2016
By modifying a technique for growing cultured intestinal tissue, researchers have developed a tissue-engineered model of the lung and trachea, which contains the diverse cell types present in the human respiratory tract.

Since the cellular and molecular mechanisms that underpin regeneration of the human lung are unknown, study of lung repair has been slowed by the necessity of using model systems that exclude key components.

Investigators at Children's Hospital Los Angeles (CA, USA) had previously developed tissue-engineered small intestine (TESI) and showed that this regenerated tissue was functional and contained all of the key components of the native tissue. More...
Based on this expertise, they hypothesized that multicellular epithelial and mesenchymal cell clusters or lung organoid units (LuOU) could be transplanted to recapitulate proximal and distal cellular structures of the native lung and airways.

The investigators described in the October 31, 2016, online edition of the journal Tissue Engineering Part C: Methods how they transplanted postnatal tissues from whole mouse and human lung, distal mouse lung, as well as mouse and human trachea onto biodegradable polymer scaffolds. The tissue obtained by using this strategy was termed tissue-engineered lung or TELu, and it contained the necessary cell types consistent with native adult lung tissue and demonstrated proliferative cells at two and four weeks. This technique recapitulated important elements of both mouse and human lungs featuring key components of both the proximal and distal lung regions.

"We think that understanding lung regeneration in this model will allow several steps forward," said senior author Dr. Tracy Grikscheit, associate professor of surgery at Children's Hospital Los Angeles. "For example, advanced stages of disease can be studied with TELu that would be impossible to fully understand in our patients. Likewise, we can more quickly apply many more therapies in this model in order to – hopefully – deliver future human therapies."

Related Links:
Children's Hospital Los Angeles



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.